A Pan-Cancer Analysis of Predictive Methylation Signatures of Response to Cancer Immunotherapy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Pan-Cancer Analysis of Predictive Methylation Signatures of Response to Cancer Immunotherapy
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-12-09
DOI
10.3389/fimmu.2021.796647
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Crosstalk between DNA methylation and gene expression in colorectal cancer, a potential plasma biomarker for tracing this tumor
- (2020) Mohammad Amin Kerachian et al. Scientific Reports
- Genetic and Epigenetic Biomarkers of Immune Checkpoint Blockade Response
- (2020) Qingyang Xiao et al. Journal of Clinical Medicine
- Minimalist approaches to cancer tissue-of-origin classification by DNA methylation
- (2020) Daniel Xia et al. MODERN PATHOLOGY
- Immune-related adverse events of checkpoint inhibitors
- (2020) Manuel Ramos-Casals et al. Nature Reviews Disease Primers
- Mathematical prediction of clinical outcomes in advanced cancer patients treated with checkpoint inhibitor immunotherapy
- (2020) Joseph D. Butner et al. Science Advances
- The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee
- (2020) Lynette M. Sholl et al. Journal of Thoracic Oncology
- A decade of immune-checkpoint inhibitors in cancer therapy
- (2020) Caroline Robert Nature Communications
- Immune Checkpoint Inhibitors for Advanced Melanoma: Experience at a Single Institution in Taiwan
- (2020) Chiao-En Wu et al. Frontiers in Oncology
- Genome-wide identification of differentially methylated promoters and enhancers associated with response to anti-PD-1 therapy in non-small cell lung cancer
- (2020) Jae-Won Cho et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Targeting the epigenetic regulation of antitumour immunity
- (2020) Simon J. Hogg et al. NATURE REVIEWS DRUG DISCOVERY
- Correlate tumor mutation burden with immune signatures in human cancers
- (2019) Xiaosheng Wang et al. BMC IMMUNOLOGY
- Machine learning-based predictors for immune checkpoint inhibitor therapy of non-small-cell lung cancer
- (2019) M Wiesweg et al. ANNALS OF ONCOLOGY
- Multi-Level Comparison of Machine Learning Classifiers and Their Performance Metrics
- (2019) Rácz et al. MOLECULES
- Association Between Tumor Mutation Burden (TMB) and Outcomes of Cancer Patients Treated With PD-1/PD-L1 Inhibitions: A Meta-Analysis
- (2019) Jiaxin Zhu et al. Frontiers in Pharmacology
- Tumor neoantigens: from basic research to clinical applications
- (2019) Tao Jiang et al. Journal of Hematology & Oncology
- Immuno-oncology drug development goes global
- (2019) Jia Xin Yu et al. NATURE REVIEWS DRUG DISCOVERY
- DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load
- (2019) Hyunchul Jung et al. Nature Communications
- A Pan-Cancer Approach to Predict Responsiveness to Immune Checkpoint Inhibitors by Machine Learning
- (2019) Maurizio Polano et al. Cancers
- Cell-Free DNA Methylation Profiling Analysis—Technologies and Bioinformatics
- (2019) Huang et al. Cancers
- Response rates and survival to systemic therapy after immune checkpoint inhibitor failure in recurrent/metastatic head and neck squamous cell carcinoma
- (2019) Roberto Carmagnani Pestana et al. ORAL ONCOLOGY
- Oncogenic Signaling Pathways in The Cancer Genome Atlas
- (2018) Francisco Sanchez-Vega et al. CELL
- Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
- (2018) Leena Gandhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biomarkers of response to immune checkpoint blockade in cancer treatment
- (2018) Takeo Fujii et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
- (2018) Sanjeev Mariathasan et al. NATURE
- Pan-cancer deconvolution of tumour composition using DNA methylation
- (2018) Ankur Chakravarthy et al. Nature Communications
- MSIpred: a python package for tumor microsatellite instability classification from tumor mutation annotation data using a support vector machine
- (2018) Chen Wang et al. Scientific Reports
- Learning from class-imbalanced data: Review of methods and applications
- (2017) Guo Haixiang et al. EXPERT SYSTEMS WITH APPLICATIONS
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
- (2017) Pornpimol Charoentong et al. Cell Reports
- Indicators of responsiveness to immune checkpoint inhibitors
- (2017) Bradley D. Shields et al. Scientific Reports
- Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
- (2016) N. McGranahan et al. SCIENCE
- Immune Checkpoint Inhibitors for Cancer Therapy: Clinical Efficacy and Safety
- (2015) Saїd Azoury et al. CURRENT CANCER DRUG TARGETS
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- NbClust: AnRPackage for Determining the Relevant Number of Clusters in a Data Set
- (2015) Malika Charrad et al. Journal of Statistical Software
- The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints
- (2014) Nicolas J. Llosa et al. Cancer Discovery
- Improved prognostic classification of breast cancer defined by antagonistic activation patterns of immune response pathway modules
- (2010) Andrew E Teschendorff et al. BMC CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search